In animal model of transplanted primary hepatic carcinoma (PCH), JDX treatment significantly inhibits tumor growth by depressing serum vascular endothelial growth factor (VEGF) level and promoting tumor cell apoptosis [14]. Here, VEGFA is linked to neoplasm.